Type
1.
Mee PT, Buultjens AH, Oliver J, Brown K, Crowder JC, Porter JL, et al. Mosquitoes provide a transmission route between possums and humans for Buruli ulcer in southeastern Australia. Nature Microbiology [Internet]. 2024;9(2):377-89. Available from: https://www.nature.com/articles/s41564-023-01553-1.pdf
Type
1.
Shyam M, Kumar S, Singh V. Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans. ACS infectious diseases. 2024;.
Type
1.
Boccarossa A, Fleuret S. Mixed Research Methods for Buruli Ulcer Prevention in Southern Benin Using Geographic Health Surveys. In: Global Perspectives on Health Geography. Springer International Publishing; 2023. pp. 91-114.
Type
1.
Warryn L, Pluschke G. Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease. CHIMIA [Internet]. 2023;77(9):577-81. Available from: https://www.chimia.ch/chimia/article/view/2023_577/6291
Type
1.
McNamara BJ, Blasdell KR, Yerramilli A, Smith IL, Clayton SL, Dunn M, et al. Comprehensive Case-Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia. Emerging infectious diseases [Internet]. 2023;29(10):2032-43. Available from: https://wwwnc.cdc.gov/eid/article/29/10/pdfs/23-0011.pdf
Type
1.
Vandelannoote K Department of Microbiology and Immunology, University of Melbourne, Buultjens AH Department of Microbiology and Immunology, University of Melbourne, Porter JL Department of Microbiology and Immunology, University of Melbourne, Velink A Department of Microbiology and Immunology, University of Melbourne, Wallace JR Department of Biology, Millersville University, Blasdell KR CSIRO Health and Biosecurity, et al. Statistical modelling based on structured surveys of Australian native possum excreta harbouring Mycobacterium ulcerans predicts Buruli ulcer occurrence in humans. eLife [Internet]. 2023;12. Available from: https://elifesciences.org/download/aHR0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0aWNsZXMvODQ5ODMvZWxpZmUtODQ5ODMtdjEucGRmP2Nhbm9uaWNhbFVyaT1odHRwczovL2VsaWZlc2NpZW5jZXMub3JnL2FydGljbGVzLzg0OTgz/elife-84983-v1.pdf?_hash=w%2FQF%2BNwAVQhyH8b0%2Fo7gZq4iQkyf00ON
Type
1.
Chandenier J, Chippaux J-P, Gazin P, Jannin J, Solano P. Contrôle, élimination, éradication : où en est-on dans les MTN ? Journée scientifique de la SFMTSI du 25 novembre 2021. Medecine tropicale et sante internationale [Internet]. 2021;1(4). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128498/pdf/mtsi-01-5326.pdf
Type
1.
Linke JA, Athan E, Friedman D. Correlation between Buruli Ulcer Incidence and Vectorborne Diseases, Southeastern Australia, 2000-2020. Emerging infectious diseases [Internet]. 2021;27(12):3191-2. Available from: https://wwwnc.cdc.gov/eid/article/27/12/pdfs/20-3182.pdf
Type
1.
Eze CC, Ekeke N, Alphonsus C, Lehman L Retired American Leprosy Missions, Rio Rancho, New Mexico, USA\newline e-mail: lfayelehman@gmail.com, Chukwu JN, Nwafor CC, et al. Effectiveness of self-care interventions for integrated morbidity management of skin neglected tropical diseases in Anambra State, Nigeria. BMC public health [Internet]. 2021;21(1):1748. Available from: https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/s12889-021-11729-1.pdf
Type
1.
Joshi G, Quadir SS, Yadav KS. Road map to the treatment of neglected tropical diseases: Nanocarriers interventions. Journal of controlled release : official journal of the Controlled Release Society. 2021;.